Nancy Lynn Snyderman MD - 29 Jun 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Role: Director
Signature: /s/ Shantale Greenson, attorney-in-fact for Nancy Snyderman
Issuer symbol: ALKS
Transactions as of: 29 Jun 2024
Net transactions value: -$35,306
Form type: 4
Filing time: 01 Jul 2024, 17:01:17 UTC
Previous filing: 14 Jun 2024
Next filing: 12 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALKS	Ordinary Shares	Options Exercise		+6,104			6,104	29 Jun 2024	Direct	F3
transaction	ALKS	Ordinary Shares	Tax liability	$35,306	-1,465	-24%	$24.10	4,639	29 Jun 2024	Direct
holding	ALKS	Ordinary Shares						20,783	29 Jun 2024	By the Snyderman Trust	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALKS	Restricted Stock Unit Award	Options Exercise		-6,104	-100%		0	29 Jun 2024	Ordinary Shares	6,104		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 427 shares purchased on March 4, 2022 and 20,356 shares transferred by the reporting person on September 6, 2023.
F2	Shares are held by the Nancy Lynn Snyderman Revocable Trust (the "Snyderman Trust"), of which the reporting person is both the sole trustee and sole beneficiary.
F3	Each restricted stock unit represents a contingent right to receive one ordinary share.
F4	This award is fully vested in accordance with its terms.